文献速递眼底病与葡萄膜炎

单甲基富马酸对光诱导视网膜病变的保护作用

Monomethyl Fumarate Protects the Retina From Light-Induced Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究在小鼠光诱导视网膜病变模型中评估单甲基富马酸(MMF)的视网膜保护作用。腹腔注射50至100 mg/kg MMF后,100 mg/kg单次给药完全保护视网膜结构和功能,且无副作用。MMF的保护作用与抑制小胶质细胞激活、炎症和氧化应激相关。

要点

  • 100 mg/kg MMF单次给药完全保护光损伤后的视网膜结构和功能。
  • MMF抑制光诱导的Hcar2受体和CD14表达上调,Hcar2表达依赖小胶质细胞。
  • MMF减轻光诱导的小胶质细胞激活、炎症基因和氧化应激基因上调。

核心结论

  • MMF能完全保护BALB/c小鼠视网膜免受光诱导视网膜病变的损伤。
  • MMF受体Hcar2在神经视网膜中的表达依赖小胶质细胞。
  • MMF的神经保护作用与减轻视网膜小胶质细胞激活、炎症和氧化应激相关。

研究设计与样本

  • 研究使用白化BALB/c小鼠,腹腔注射50至100 mg/kg MMF,在暴露于10,000 lux亮白光1小时之前或之后给药。
  • 光暴露后7天通过OCT和ERG评估视网膜结构和功能,并进行视网膜组织学评估光感受器丢失。
  • 通过qPCR测量神经视网膜中Hcar2和小胶质细胞激活标志物的表达,并评估小胶质细胞清除的影响。
  • 光暴露后24小时用Iba1染色评估小胶质细胞状态,通过qPCR和Western blot检测NF-κB和Nrf2通路。

主要发现

  • 光暴露前给予MMF在光诱导视网膜病变小鼠模型中产生剂量依赖性神经保护。
  • 100 mg/kg MMF单次给药完全保护视网膜结构和功能,且无副作用。
  • 光诱导视网膜病变上调Hcar2受体和小胶质细胞标志物Cd14的表达,而MMF抑制这种上调。
  • 清除小胶质细胞降低Hcar2表达及其由光诱导视网膜病变引起的上调。
  • MMF减轻光诱导视网膜病变相关的小胶质细胞激活、促炎基因(Nlrp3、Caspase1、Il-1β、Tnf-α)上调和抗氧化应激基因(Hmox1)上调。

临床怎么用

  • MMF在光诱导视网膜病变小鼠模型中显示剂量依赖性神经保护,100 mg/kg单次给药完全保护视网膜结构和功能。
  • MMF的保护作用与抑制小胶质细胞激活、炎症和氧化应激相关,提示其可能作为光损伤相关视网膜病变的潜在干预药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We determine if monomethyl fumarate (MMF) can protect the retina in mice subjected to light-induced retinopathy (LIR). METHODS: Albino BALB/c mice were intraperitoneally injected with 50 to 100 mg/kg MMF before or after exposure to bright white light (10,000 lux) for 1 hour. Seven days after light exposure, retinal structure and function were evaluated by optical coherence tomography (OCT) and electroretinography (ERG), respectively. Retinal histology also was performed to evaluate photoreceptor loss. Expression levels of Hcar2 and markers of microglia activation were measured by quantitative PCR (qPCR) in the neural retina with and without microglia depletion. At 24 hours after light exposure, retinal sections and whole mount retinas were stained with Iba1 to evaluate microglia status. The effect of MMF on the nuclear factor kB subunit 1 (NF-kB) and Nrf2 pathways was measured by qPCR and Western blot. RESULTS: MMF administered before light exposure mediated dose-dependent neuroprotection in a mouse model of LIR. A single dose of 100 mg/kg MMF fully protected retinal structure and function without side effects. Expression of the Hcar2 receptor and the microglia marker Cd14 were upregulated by LIR, but suppressed by MMF. Depleting microglia reduced Hcar2 expression and its upregulation by LIR. Microglial activation, upregulation of proinflammatory genes (Nlrp3, Caspase1, Il-1β, Tnf-α), and upregulation of antioxidative stress genes (Hmox1) associated with LIR were mitigated by MMF treatment. CONCLUSIONS: MMF can completely protect the retina from LIR in BALB/c mice. Expression of Hcar2, the receptor of MMF, is microglia-dependent in the neural retina. MMF-mediated neuroprotection was associated with attenuation of microglia activation, inflammation and oxidative stress in the retina.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Jiang D, Ryals RC, Huang SJ, et al. Monomethyl Fumarate Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2019. PMID: 30924852. doi:10.1167/iovs.18-24398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。